Evan John Slater is a pharmacist who is specialized in Oncology in Denver, Colorado. Patients can reach him at 4700 Hale Pkwy Ste 400, Denver or contact him on 303-285-5085. Active license number of Evan John Slater is 16683 for Oncology in Colorado. Evan John Slater is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Evan John Slater speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Evan John Slater
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Male
Location:
4700 Hale Pkwy Ste 400, Denver, Colorado, 80220-4051
Phone:
303-285-5085
Fax:
303-930-5517
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Evan John Slater are as mentioned below.
NPI Number:
1902311640
NPI Enumeration Date:
04 Dec, 2017
NPI Last Update On:
04 Dec, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Evan John Slater are as mentioned below.
Specialization
License Number
State
Status
Oncology
16683
Colorado
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4700 Hale Pkwy Ste 400, Denver, Colorado
Zip:
80220-4051
Phone Number:
303-285-5085
Fax Number:
303-930-5517
Patients can reach Evan John Slater at 4700 Hale Pkwy Ste 400, Denver, Colorado or can call on phone at 303-285-5085.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.